Ramkaran Prithiksha, Phulukdaree Alisa, Khan Sajidah, Moodley Devapregasan, Chuturgoon Anil A
Discipline of Medical Biochemistry and Chemical Pathology, University of KwaZulu-Natal, Durban, South Africa.
Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, South Africa.
Cardiovasc J Afr. 2016 Jul/Aug;27(4):213-217. doi: 10.5830/CVJA-2015-085.
Sirtuin 1 (SIRT1), a class III histone deacetylase, has been identified as a candidate molecule affecting the epigenetic mechanisms of cardiovascular disease (CVD). Previous studies have shown that some SIRT1 single-nucleotide polymorphisms (SNPs) are associated with body mass index, diabetes, blood pressure, cholesterol metabolism and coronary artery calcification. We investigated two A>G SIRT1 SNPs, rs1467568 and rs7895833, in young South African (SA) Indians with coronary artery disease (CAD) and compared them to Indian and black controls.
For rs1467568, a total of 287 subjects were recruited into this study (104 CAD patients, 99 age-, gender- and race-matched controls, and 84 age- and gender-matched black controls). For rs7895833, a total of 281 subjects were recruited into this study (100 CAD patients, 99 age-, gender- and race-matched controls, and 82 age- and gender-matched black controls). All patients were male, of Indian ethnicity, stable CAD confirmed on angiography, mean age 37.5 years; range 24-45. All subjects were genotyped using TaqMan SNP genotyping assays.
The variant allele for both SNPs was found at a higher frequency in the total Indian group compared to the total black population (rs1467568: 41 vs 18.5%, respectively, p < 0.0001, OR = 3.190, 95% CI: 2.058-40943; and rs7895833: 41 vs 22%, respectively, p < 0.0001, OR = 2.466, 95% CI: 1.620- 3.755). Indian controls presented with a higher frequency for both SNPs compared to black controls (rs1467568: 40 vs 18.5%, respectively, p < 0.0001, OR = 2.996, 95% CI: 1.850- 4.853; and rs7895833: 41 vs 22%, respectively, p < 0.0001, OR = 2.513, 95% CI: 1.578-4.004). No difference was seen in the distribution of both SNPs between CAD patients and either control group. We did not observe any association between the SNPs and clinical parameters in CAD patients and controls.
Both SNP variant alleles occurred more frequently in SA Indians than in SA blacks. A larger study group and further analysis is required to assess whether these SIRT1 SNPs may serve as risk factors that contribute to Indians developing early-onset CAD.
沉默调节蛋白1(SIRT1)是一种III类组蛋白去乙酰化酶,已被确定为影响心血管疾病(CVD)表观遗传机制的候选分子。先前的研究表明,一些SIRT1单核苷酸多态性(SNP)与体重指数、糖尿病、血压、胆固醇代谢和冠状动脉钙化有关。我们在患有冠状动脉疾病(CAD)的南非(SA)年轻印度裔人群中研究了两个SIRT1基因的A>G SNP,即rs1467568和rs7895833,并将其与印度裔和黑人对照组进行比较。
对于rs1467568,本研究共招募了287名受试者(104例CAD患者、99名年龄、性别和种族匹配的对照组以及84名年龄和性别匹配的黑人对照组)。对于rs7895833,本研究共招募了281名受试者(100例CAD患者、99名年龄、性别和种族匹配的对照组以及82名年龄和性别匹配的黑人对照组)。所有患者均为印度裔男性,血管造影确诊为稳定型CAD,平均年龄37.5岁;年龄范围为24 - 45岁。所有受试者均使用TaqMan SNP基因分型检测进行基因分型。
与总黑人人群相比,两个SNP的变异等位基因在总印度人群中的出现频率更高(rs1467568:分别为41%和18.5%,p < 0.0001,OR = 3.190,95% CI:2.058 - 4.0943;rs7895833:分别为41%和22%,p < 0.0001,OR = 2.466,95% CI:1.620 - 3.755)。与黑人对照组相比,印度裔对照组中两个SNP的出现频率更高(rs1467568:分别为40%和18.5%,p < 0.0001,OR = 2.996,95% CI:1.850 - 4.853;rs7895833:分别为41%和22%,p < 0.0001,OR = 2.513,95% CI:1.578 - 4.004)。CAD患者与任一对照组之间两个SNP的分布均无差异。我们未观察到CAD患者和对照组中SNP与临床参数之间存在任何关联。
两个SNP变异等位基因在南非印度裔人群中的出现频率高于南非黑人。需要更大的研究群体和进一步分析来评估这些SIRT1 SNP是否可能作为导致印度裔人群患早发性CAD的危险因素。